62 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
9
Ending by 2030
Jan 2027
Next term end
15
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2033 · High confidence
Also notable
Ends Oct 2032 · Low confidence
Also notable
Ends May 2027 · Low confidence
Combination Treatment Systems
US 11,285,040
Cited by 43 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2033.
Ocular Delivery Systems and Methods
US 11,617,679
Cited by 24 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
Intraocular Implants and Methods and Kits Therefor
US 11,389,328
Cited by 35 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 4, 2027The maintenance fee for Ocular Delivery Systems and Methods (US 9,095,412) comes due Feb 4, 2027. Unpaid by Aug 4, 2027, it lapses early.
- 1 fee due Mar 10, 2027The maintenance fee for Intraocular Implants and Related Kits and Methods (US 10,406,030) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
- 1 fee due Jun 22, 2027The maintenance fee for Ocular Delivery Systems and Methods (US 9,216,109) comes due Jun 22, 2027. Unpaid by Dec 22, 2027, it lapses early.
- 3 fees due Jul 2 to 23, 2027 · next Jul 2
- 1 fee due Sep 12, 2027The maintenance fee for Formulations and Methods for Treating Conditions of the Eye (US 11,925,657) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
- 1 fee due Oct 9, 2027The maintenance fee for Ocular Delivery Systems and Methods (US 11,951,037) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 16, 2026
What they patent
The 5 largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Dry Eye Treatment Apparatus and Methods | 12 in force | to Nov 2034 |
| Ocular Delivery Systems and Methods (2012) | 11 in force | to Mar 2034 |
| Intraocular Implants and Methods and Kits Therefor | 9 in force | to Oct 2029 |
| Ocular Delivery Systems and Methods (2012) | 6 in force | to Jun 2035 |
| Intraocular Implants and Related Kits and Methods | 6 in force | to Jun 2032 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,398,597 | Intraocular Implants and Methods and Kits Therefor In force · Medium confidence | In force | Medium confidence | |
| US 11,865,041 | Intraocular Implants and Methods and Kits Therefor In force · Low confidence | In force | Low confidence | |
| US 8,287,482 | Intraocular Implants and Methods and Kits Therefor In force · Medium confidence | In force | Medium confidence | |
| US 10,314,742 | Intraocular Implants and Methods and Kits Therefor In force · Low confidence | In force | Low confidence | |
| US 11,389,328 | Intraocular Implants and Methods and Kits Therefor In force · Low confidence | In force | Low confidence | |
| US 12,551,376 | Intraocular Implants and Methods and Kits Therefor In force · Low confidence | In force | Low confidence | |
| US 9,486,361 | Intraocular Implants and Methods and Kits Therefor In force · Medium confidence | In force | Medium confidence | |
| US 9,370,443 | Intraocular Implants and Methods and Kits Therefor In force · Medium confidence | In force | Medium confidence | |
| US 7,909,789 | Intraocular Implants and Methods and Kits Therefor In force · High confidence | In force | High confidence | |
| US 8,439,972 | Intraocular Implants and Related Kits and Methods In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 62: 20 applications pending · 9 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.